MedPath

UREA

Urea Cream 40%

Approved
Approval ID

65f56eff-4f67-4cbf-a801-a632261afc29

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 4, 2024

Manufacturers
FDA

AvKARE

DUNS: 796560394

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

UREA

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42291-849
Product Classification
G
Generic Name
UREA
Product Specifications
Route of AdministrationTOPICAL
Effective DateApril 4, 2024
FDA Product Classification

INGREDIENTS (7)

PARAFFINInactive
Code: I9O0E3H2ZE
Classification: IACT
UREAActive
Quantity: 40 g in 100 g
Code: 8W8T17847W
Classification: ACTIB
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
CETYL ALCOHOLInactive
Code: 936JST6JCN
Classification: IACT
STEARYL ALCOHOLInactive
Code: 2KR89I4H1Y
Classification: IACT
XANTHAN GUMInactive
Code: TTV12P4NEE
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 10/6/2021

Tube Label

28.35

29

85

198.4

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 9/1/2014

Indications and Usage

For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis palmaris, keratoderma, corns and calluses, as well as damaged, ingrown and devitalized nails.

CONTRAINDICATIONS SECTION

LOINC: 34070-3Updated: 9/1/2014

Contraindications

Known hypersensitivity to any of the listed ingredients.

ADVERSE REACTIONS SECTION

LOINC: 34084-4Updated: 11/6/2017

Adverse Reactions

Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the medication.


To report SUSPECTED ADVERSE REACTIONS contact AvKARE, Inc. at 1-855-361-3993; email drugsafety@avkare.com; or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatch.

WARNINGS SECTION

LOINC: 34071-1Updated: 9/1/2014

Warnings

For topical use only. Avoid contact with eyes, lips or mucous membranes.

DESCRIPTION SECTION

LOINC: 34089-3Updated: 10/23/2017

Rx Only

For external use only. Not for ophthalmic use.

Description

Urea 40% is a keratolytic emollient which is a gentle, yet potent, tissue softener for nails and/or skin. Each gram of Urea 40%contains 40% urea as an active ingredient, and the following inactive ingredients:

Carbomer, Cetearyl Alcohol, Glycerin,

Glyceryl Stearate SE, Mineral Oil, Purified Water,

White Petrolatum

Urea is a diamide of carbonic acid with the following chemical structure:

structure

CLINICAL PHARMACOLOGY SECTION

LOINC: 34090-1Updated: 9/1/2014

Clinical Pharmacology

Urea gently dissolves the intracellular matrix which results in loosening of the horny layer of the skin and shedding of scaly skin at regular intervals, thereby softening hyperkeratotic areas of the skin.

PHARMACOKINETICS SECTION

LOINC: 43682-4Updated: 9/1/2014

Pharmacokinetics

The mechanism of action of topically applied urea is not yet known.

PRECAUTIONS SECTION

LOINC: 42232-9Updated: 9/1/2014

Precautions

This medication is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use and consult a physician.

PREGNANCY SECTION

LOINC: 42228-7Updated: 11/6/2017

PREGNANCY: Pregnancy Category B. Animal reproduction studies have revealed no evidence of harm to the fetus, however, there are no adequate and well- controlled studies in pregnant women. Because animal reproductive studies are not always predictive of human response, Urea 40% should be given to a pregnant woman only if clearly needed.

NURSING MOTHERS SECTION

LOINC: 34080-2Updated: 10/5/2017

NURSING MOTHERS: It is not known whether or not this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Urea 40% is administered to a nursing woman.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 9/1/2014

Dosage and Administration

Apply Urea 40% to affected skin twice per day, or as directed by your physician. Rub in until completely absorbed.
Apply to diseased or damaged nail(s) twice per day, or as directed by a physician.

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 11/6/2017

How Supplied

Urea 40% Cream

1 oz. (28.35 g):

Bottle NDC 42291-849-28

Tube NDC 42291-849-29

Urea 40% Cream

3 oz. (85 g): NDC 42291-849-85

Urea 40% Cream

7 oz. (198.4 g): NDC 42291-849-19

Store at room temperature 15°C - 30°C (59°F-86°F).

Protect from freezing. Keep bottle tightly closed.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

Manufactured for:
AvKARE
Pulaski, TN 38478

AV 06/22

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

UREA - FDA Drug Approval Details